Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 171482)

Published in Antimicrob Agents Chemother on March 01, 1989

Authors

W J Page1, G Huyer, M Huyer, E A Worobec

Author Affiliations

1: Department of Microbiology, University of Alberta, Edmonton, Canada.

Articles citing this

Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18

The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect Immun (1995) 2.03

The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81

Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother (1991) 1.67

Identification of surface-exposed outer membrane antigens of Helicobacter pylori. Infect Immun (1994) 1.61

Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect Immun (2000) 1.56

Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother (1991) 1.55

Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother (1995) 1.38

Isolation and characterization of a conserved porin protein from Helicobacter pylori. J Bacteriol (1995) 1.31

Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents. Antimicrob Agents Chemother (1995) 1.21

Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother (1996) 1.13

Purification, characterization and sequence analysis of Omp50,a new porin isolated from Campylobacter jejuni. Biochem J (2000) 1.05

The C-terminal domain of the Bordetella pertussis autotransporter BrkA forms a pore in lipid bilayer membranes. J Bacteriol (1999) 1.04

Resistance mechanisms in Campylobacter jejuni. Virulence (2013) 1.04

Environmental regulation of Campylobacter jejuni major outer membrane protein porin expression in Escherichia coli monitored by using green fluorescent protein. Appl Environ Microbiol (2002) 0.91

Genetic diversity and stability of the porA allele as a genetic marker in human Campylobacter infection. Microbiology (2009) 0.85

MOMP from Campylobacter jejuni Is a Trimer of 18-Stranded β-Barrel Monomers with a Ca(2+) Ion Bound at the Constriction Zone. J Mol Biol (2016) 0.78

Peptide translocation across MOMP, the major outer membrane channel from Campylobacter jejuni. Biochem Biophys Rep (2017) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51

Campylobacter enteritis. Clin Gastroenterol (1979) 18.67

Molecular basis of bacterial outer membrane permeability. Microbiol Rev (1985) 17.75

Filtration, diffusion, and molecular sieving through porous cellulose membranes. J Gen Physiol (1954) 11.50

Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta (1976) 7.44

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45

Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1983) 5.21

Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J Bacteriol (1983) 5.20

Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu Rev Microbiol (1987) 4.78

Determination of the effective hydrodynamic radii of small molecules by viscometry. J Gen Physiol (1961) 4.56

Alterations in outer membrane permeability. Annu Rev Microbiol (1984) 4.22

Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 4.13

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00

Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. J Gen Physiol (1981) 3.72

Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01. Biochim Biophys Acta (1979) 3.70

In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. Antimicrob Agents Chemother (1986) 3.38

Campylobacter pylori, the spiral bacterium associated with human gastritis, is not a true Campylobacter sp. J Bacteriol (1987) 3.17

Ion selectivity of gram-negative bacterial porins. J Bacteriol (1985) 2.87

In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother (1983) 2.70

Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother (1984) 2.43

Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43

Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1983) 2.40

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36

Role of permeability barriers in resistance to beta-lactam antibiotics. Pharmacol Ther (1985) 2.32

Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother (1979) 2.29

Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother (1988) 2.26

Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun (1984) 2.23

Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23

Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F. J Bacteriol (1986) 2.15

Porin channel triplets merge into single outlets in Escherichia coli outer membranes. Nature (1985) 1.89

Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels. Antimicrob Agents Chemother (1982) 1.88

Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67

Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother (1985) 1.60

Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J Antimicrob Chemother (1986) 1.57

Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother (1983) 1.53

Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52

Iron- and molybdenum-repressible outer membrane proteins in competent Azotobacter vinelandii. J Bacteriol (1982) 1.51

LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studies. J Antibiot (Tokyo) (1983) 1.47

Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother (1987) 1.29

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother (1985) 1.29

Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother (1987) 1.27

Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25

Tetracyclines of various hydrophobicities as a probe for permeability of Escherichia coli outer membranes. Antimicrob Agents Chemother (1984) 1.25

Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol (1986) 1.25

Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18

Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli. J Antimicrob Chemother (1986) 1.13

Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics. Antimicrob Agents Chemother (1987) 1.12

Genetic studies of kanamycin resistance in Campylobacter jejuni. Antimicrob Agents Chemother (1986) 1.06

Immunoblot and enzyme-linked immunosorbent assays of Campylobacter major outer-membrane protein and application to the differentiation of Campylobacter species. Mol Cell Probes (1987) 0.95

Comparison of methods used to separate the inner and outer membranes of cell envelopes of Campylobacter spp. J Gen Microbiol (1988) 0.94

Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa. Antibiot Chemother (1971) (1987) 0.88

Structure of the porin from a bacterial stalk. FEBS Lett (1987) 0.84

Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 0.80

Articles by these authors

Yeast vacuolar proenzymes are sorted in the late Golgi complex and transported to the vacuole via a prevacuolar endosome-like compartment. J Cell Biol (1993) 3.25

Derepression of the Azotobacter vinelandii siderophore system, using iron-containing minerals to limit iron repletion. J Bacteriol (1984) 1.83

Localization of the major antigenic determinant of EDP208 pili at the N-terminus of the pilus protein. J Bacteriol (1983) 1.33

Identification of pilin pools in the membranes of Pseudomonas aeruginosa. J Bacteriol (1982) 1.31

The OprB porin plays a central role in carbohydrate uptake in Pseudomonas aeruginosa. J Bacteriol (1995) 1.23

Yeast as a model system for studying endocytosis. Exp Cell Res (2001) 1.17

Antigen-antibody interaction. The immunodominant region of EDP208 pili. J Biol Chem (1985) 1.06

Regulation of components of the Pseudomonas aeruginosa phosphate-starvation-inducible regulon in Escherichia coli. Mol Microbiol (1988) 1.02

Identification of a human erythrocyte receptor for colonization factor antigen I pili expressed by H10407 enterotoxigenic Escherichia coli. Infect Immun (1988) 1.02

Monoclonal antibodies against colonization factor antigen I pili from enterotoxigenic Escherichia coli. Infect Immun (1983) 0.99

Cloning of the Pseudomonas aeruginosa outer membrane porin protein P gene: evidence for a linked region of DNA homology. J Bacteriol (1988) 0.96

Formation of poly(hydroxybutyrate-co-hydroxyvalerate) by Azotobacter vinelandii UWD. Appl Environ Microbiol (1992) 0.95

Comparison of methods used to separate the inner and outer membranes of cell envelopes of Campylobacter spp. J Gen Microbiol (1988) 0.94

Identification and characterization of the gltK gene encoding a membrane-associated glucose transport protein of pseudomonas aeruginosa. Gene (2000) 0.93

Isolation and characterization of two immunochemically distinct alkaline phosphatases from Pseudomonas aeruginosa. FEMS Microbiol Lett (1993) 0.91

Biophysical characterization of OprB, a glucose-inducible porin of Pseudomonas aeruginosa. J Bioenerg Biomembr (1993) 0.91

Cloning and nucleotide sequence of the Pseudomonas aeruginosa glucose-selective OprB porin gene and distribution of OprB within the family Pseudomonadaceae. Eur J Biochem (1994) 0.89

Location of the antigenic determinants of conjugative F-like pili. J Bacteriol (1986) 0.89

Channel specificity and secondary structure of the glucose-inducible porins of Pseudomonas spp. J Bioenerg Biomembr (1998) 0.84

Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Can J Microbiol (2004) 0.83

Reconstitution of glucose uptake and chemotaxis in Pseudomonas aeruginosa glucose transport defective mutants. Can J Microbiol (1993) 0.81

The DNA gyrase inhibitors, nalidixic acid and oxolinic acid, prevent iron-mediated repression of catechol siderophore synthesis in Azotobacter vinelandii. Biol Met (1988) 0.81

Multiple environmental factors regulate the expression of the carbohydrate-selective OprB porin of Pseudomonas aeruginosa. Can J Microbiol (1999) 0.80

Iron binding to Azotobacter salinestris melanin, iron mobilization and uptake mediated by siderophores. Biometals (1995) 0.80

An autosampler for fermentation. Biotechniques (1993) 0.80

Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Serratia marcescens. Indian J Med Microbiol (2012) 0.78

Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures. Mol Endocrinol (1991) 0.77

Production and characterization of biologically active Ala-Ser-(His)6-Ile-Glu-Gly-Arg-human prolactin (tag-hPRL) secreted in the periplasmic space of Escherichia coli. Biotechnol Appl Biochem (1996) 0.76

A two-component affinity chromatography purification of Helix pomatia arylsulfatase by tyrosine vanadate. Protein Expr Purif (1999) 0.75

Analysis of disulphide bridge function in recombinant bovine prolactin using site-specific mutagenesis and renaturation under mild alkaline conditions: a crucial role for the central disulphide bridge in the mitogenic activity of the hormone. Protein Eng (1992) 0.75

Substrate specificity of the high-affinity glucose transport system of Pseudomonas aeruginosa. Can J Microbiol (1993) 0.75